Articles by Larissa Ku
Vision Knight leads Series B for China education app
Shaonian Dedao, a Chinese education app for teenagers led by former CCTV host Quanlin Zhang, has raised RMB200 million ($29 million) in a Series B funding round led by Vision Knight Capital.
China cybersecurity provider BambooCloud raises $44m
Shenzhen-based cybersecurity company BambooCloud has raised a RMB300 million ($44 million) Series C round featuring Sequoia Capital China.
China's Gaorong closes Fund V at $1.1b
Gaorong Capital has closed its fifth US dollar-denominated fund with commitments of $1.15 billion. It brings the Chinese venture capital firm's assets under management to about $4 billion.
Tencent leads $100m round for China education platform
Huohua Siwei, a China-based children's online education platform specializing in mathematics and science, has raised $100 million in the second tranche of the Series E round.
Lee's Pharmaceutical spin-out gets $145m Series B
Hong Kong-based Zhaoke Ophthalmology Pharmaceutical (ZKO), a subsidiary of Lee’s Pharmaceutical, has raised a $145 million Series B round led by Hillhouse Capital and TPG Asia.
Fund focus: BA Capital backs youth
ByteDance spinout BA Capital has raised $147 million for its second renminbi-denominated fund and is also raising a US dollar vehicle. Backing consumer brands that resonate with young people underpins the investment thesis
Fund focus: CCV raises $300m for China fund
China Creation Ventures secures $300 million for Fund II, having found that some LPs are holding back on China commitments while others are even more willing to engage
SBI, Sygnum launch digital assets fund
SBI Ven Capital, an investment arm of Japan's SBI Group, has teamed up with digital asset bank Sygnum Group and launched an early-stage fund investing in digital assets across Southeast Asia and Europe.
Genor Biopharma raises $372m in Hong Kong IPO
China-based Genor Biopharma, which counts Hillhouse Capital, Temasek Holdings and Qiming Venture Partners among its investors, has raised HK$2.88 billion ($372 million) through a Hong Kong IPO.
CDH, Oriza back Canadian Solar carve-out
Canadian Solar, a NASDAQ-listed solar power company, has raised RMB1.78 billion ($260 million) to carve out certain China-based assets ahead of a local IPO.
China's Hinova Pharma raises $147m Series C
Hinova Pharma, a Chinese drug developer has raised RMB1 billion ($147 million) in Series C funding from Shenzhen Investment, Hong Kong-listed Tigermed, Huarong Rongde Asset Management, CCB Internationa, and a fund run by Sinopharm Group and CICC Capital....
GP profile: Redpoint China Ventures
Redpoint China Ventures spun out from its US parent in 2016, but the knowledge it retained – and the communication that remains – has been key to moving early on enterprise technology
Linear raises $200m for China VC fund
Chinese venture capital firm Linear Capital has closed its fourth US dollar-denominated fund at nearly $200 million, taking its overall assets under management to $400 million.
China's M31 Capital closes debut fund at $450m
Chinese Venture Capital firm M31 Capital has raised $450 million for its debut US dollar-denominated fund, beating a target of $400 million.
China healthcare SaaS player Taimei raises $176m
Taimei Technology, a Chinese cloud-based software provider that serves the healthcare sector has raised RMB1.2 billion ($176 million) in funding led by Tencent Holdings, GL Ventures and Yunfeng Capital.
Vision Fund leads $319m round for China's XtalPi
China and US-based artificial intelligence-enabled drug development platform XtalPi has raised $319 million in Series C funding led by SoftBank Vision Fund, the investment arm of insurer PICC Group, and Morningside Venture Capital.
Trustbridge assumes control of WeWork China
Trustbridge Partners has committed $200 million to WeWork's China operation as part of a deal that sees the business become fully independent from its US-headquartered parent.
Fund focus: Qiming's cleantech team spins out, raises $73m fund
Inspiration Capital, a spinout from Qiming Venture Partners, has raised RMB500 million for its debut fund that focuses on cleantech and advanced manufacturing investments in China
BA Capital raises $147m for renminbi fund, hits first close on dollar fund
BA Capital, a Shanghai-based venture capital firm also known as Black Ant Capital, has raised RMB1 billion ($147 million) for its second renminbi-denominated fund.
China robotics player Cyclone gets $40m Series B
Matrix Partners China has led a $40 million Series B round for local robotics start-up Cyclone. Other investors include DCM, Lenovo Capital, Source Code Capital, and Renzhi Capital.
China AI: A rude awakening
Two years ago, artificial intelligence start-ups were the bright young things of China’s technology sector. Now these companies are struggling to justify their lofty valuations
China mobile recycling platform Aihuishou raises $100m
JD.com and Guotai Junan Securities have co-led an extended Series E round of $100 million for Aihuishou, a China-based electronic products recycling platform.
China EV maker WM Motor raises $1.5b
Chinese electric vehicle (EV) manufacturer WM Motor has raised RMB10 billion ($1.47 billion) in funding led by SAIC Motor and several government investment platforms. It said to be the largest single round in China's EV industry.
CDH, SDIC lead $62m Series C for Virogin Biotech
Virogin Biotech, a drug developer based in China and Canada, has received $62 million in Series C funding led by CDH Invesmtents and a subsidiary of State Development and Investment Corporation (SDIC).